The Chronicle of Higher Education
News Blog
In the Comments

"We'd like to think that doctors are somehow immune to the influence of advertising, but turns out they're human after all.
— Debbie C

Drug-Company Association Bans Freebies for Doctors

Recent Posts

Another Giuliani Finds His Dream Deferred

Bible Professor Will Leave Seminary Instead of Facing Hearing

Purdue U. Scientist Appeals Findings of Research Misconduct

Embattled Congressman Calls for Investigation Into His Actions on Behalf of CCNY

Baylor U. Regents Fire President, Citing Failure to Unite Campus


Most Commented This Month

Closed Out? Norman Finkelstein, Controversial Scholar Denied Tenure, Can't Find a Job. | 104

Group Argues That Out-of-Class Learning Is Domain of Faculty, Not Student Affairs | 92

Is There a 'Growing Backlash' Against the SAT? | 59

College Settles With Instructor Fired for Teaching Adam and Eve as Myth | 54

Fresh Artistic Controversy Hits Yale U. | 52

By Category

Athletics
Community Colleges
Government & Politics
Information Technology
International
Money & Management
Northern Illinois
Research & Books
Short Subjects
Students
The Faculty

Blog Archives

Search

Keep Up to Date

Daily news blog: RSS  / Atom

Daily news reported by The Chronicle: RSS

Contact us

June 2, 2006

University Pulls Cardiologist From Human-Subjects Research

The University of Arizona has barred a cardiologist from conducting research on human subjects because of violations of scientific standards during a nationwide study of an experimental pacemaker, according to articles in Wednesday’s Arizona Daily Star and Tucson Citizen. The researcher, Paul Fenster, who is an associate professor of medicine, dismissed the violations as mere “clerical mistakes.” The university uncovered the problems in the course of a routine audit, and turned its suspicions over to the U.S. Food and Drug Administration, which has jurisdiction over medical devices like pacemakers.

The FDA found that the professor had failed to obtain informed consent from patients, among other violations, although it was unclear if any of them had been harmed as a result. The study, which was sponsored by the device’s manufacturer, the Guidant Corporation, concluded that the pacemaker helped lengthen the survival of heart patients. Results of the study. including those patients under Dr. Fenster’s care, were published in The New England Journal of Medicine.

Posted on Friday June 2, 2006 | Permalink |